EUVIMEDEUVIMED entdecken
Crossref

Enhanced Analgesic Efficacy and Reduced Side Effects of Morphine by Combination with PD-1 Agonist

Xiaofei Song, Ying Zhang, Yuxin Liu, Gang Chen, Long Zhao iD

ACS Chemical Neuroscience · 2025

DOI: 10.1021/acschemneuro.4c00732 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Xiaofei Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Basic Medical Research, Medical School of Nantong University, Nantong 226001, P. R. China. Hauptthemen laut MEDLINE: Morphine, Analgesics, Opioid, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: ?333 Project? of Jiangsu Province, High Level Innovation and Entrepreneurial Research Team Program in Jiangsu, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic pain is a debilitating disease and remains challenging to treat. Morphine serves as the most commonly used drug for the treatment of pathological pain. However, detrimental side effects (e.g., hyperalgesia and tolerance) manifest during chronic administration, thus counteracting morphine analgesia. Investigators have sought methods to widen the therapeutic window of morphine in the management of chronic pain. Programmed cell death protein 1 (PD-1) is a recently validated analgesic target and is coexpressed with the mu opioid receptor (μOR) in dorsal root ganglion (DRG) sensory neurons. Here, we present evidence that PD-1 regulates the expression of μOR mRNA and influences μOR-mediated analgesia. Notably, the concomitant administration of PD-1 agonist H-20 greatly reduces the dosage of morphine needed for analgesia, thereby significantly decreasing opioid-related side effects. This new combination therapy may provide a solution for managing chronic pain in patients who require morphine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MorphineAnalgesics, OpioidProgrammed Cell Death 1 ReceptorAnimalsGanglia, SpinalReceptors, Opioid, muMaleChronic PainMiceDrug Therapy, CombinationRats, Sprague-Dawley

Stichwörter der Autor:innen

analgesiachronic painconcomitant administrationprogrammed cell death protein 1μ opioid receptor

Substanzen

MorphineAnalgesics, OpioidReceptors, Opioid, muProgrammed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Center for Basic Medical Research, Medical School of Nantong University, Nantong 226001, P. R. China.
  • Department of Histology and Embryology, Medical School of Nantong University, Nantong 226001, P. R. China.
  • Department of Anesthesiology, Affiliated Hospital of Nantong University, Nantong 226001, P. R. China.

ORCID-Profile: Long Zhao

Förderung

  • ?333 Project? of Jiangsu Province
  • High Level Innovation and Entrepreneurial Research Team Program in Jiangsu
  • National Natural Science Foundation of China

Zitieren

APA

Song, X., Zhang, Y., Liu, Y., Chen, G., & Zhao, L. (2025). Enhanced Analgesic Efficacy and Reduced Side Effects of Morphine by Combination with PD-1 Agonist. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00732

Vancouver

Song X, Zhang Y, Liu Y, Chen G, Zhao L. Enhanced Analgesic Efficacy and Reduced Side Effects of Morphine by Combination with PD-1 Agonist. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.4c00732

BibTeX
@article{Song2025,
  author = {Song, Xiaofei and Zhang, Ying and Liu, Yuxin and Chen, Gang and Zhao, Long},
  title = {Enhanced Analgesic Efficacy and Reduced Side Effects of Morphine by Combination with PD-1 Agonist},
  journal = {ACS Chemical Neuroscience},
  year = {2025},
  doi = {10.1021/acschemneuro.4c00732}
}
Kostenlos starten →